InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HEA | Ann: Consolidation of Capital Completed - Appendi | 03/09/12 | 0 | 259 | |||
|
|||||||
HEA | Ann: Change of Name and Completion of Consolidati | 03/09/12 | 0 | 290 | |||
|
|||||||
HEA | Ann: Preliminary Final Report | 31/08/12 | 0 | 276 | |||
|
|||||||
HEA | Ann: Appendix 3Y - Change of Director's Inter | 21/08/12 | 0 | 215 | |||
|
|||||||
HEA | Ann: Results of General Meeting | 17/08/12 | 0 | 323 | |||
|
|||||||
HEA | Ann: Suspension from Official Quotation | 18:02 | 0 | 182 | |||
|
|||||||
HEA | Ann: Appendix 3Y - Change of Director's Inter | 10/08/12 | 0 | 217 | |||
|
|||||||
HEA | Ann: Appendix 3Y - Change of Director's Inter | 06/08/12 | 0 | 152 | |||
|
See All Discussions